Smith & Nephew SNATS Receivables 2010-2024 | SNN
Smith & Nephew SNATS receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
- Smith & Nephew SNATS receivables for the quarter ending December 31, 2024 were $1.415B, a 12.93% increase year-over-year.
- Smith & Nephew SNATS receivables for 2024 were $1.415B, a 6.15% increase from 2023.
- Smith & Nephew SNATS receivables for 2023 were $1.333B, a 2.46% increase from 2022.
- Smith & Nephew SNATS receivables for 2022 were $1.301B, a 0.85% increase from 2021.
| Smith & Nephew SNATS Annual Receivables (Millions of US $) |
|
|---|---|
| 2024 | $1,415 |
| 2023 | $1,333 |
| 2022 | $1,301 |
| 2021 | $1,290 |
| 2020 | $1,211 |
| 2019 | $1,328 |
| 2018 | $1,317 |
| 2017 | $1,258 |
| 2016 | $1,185 |
| 2015 | $1,138 |
| 2014 | $1,166 |
| 2013 | $1,113 |
| 2012 | $1,065 |
| 2011 | $1,037 |
| 2010 | $1,024 |
| 2009 | $946 |
| Smith & Nephew SNATS Quarterly Receivables (Millions of US $) |
|
|---|---|
| 2024-12-31 | $1,415 |
| 2023-12-31 | $1,333 |
| 2023-06-30 | $1,277 |
| 2022-12-31 | $1,301 |
| 2022-06-30 | $1,253 |
| 2021-12-31 | $1,290 |
| 2021-06-30 | $1,305 |
| 2020-12-31 | $1,211 |
| 2020-06-30 | $1,231 |
| 2019-12-31 | $1,328 |
| 2019-06-30 | $1,280 |
| 2018-12-31 | $1,317 |
| 2018-06-30 | $1,205 |
| 2017-12-31 | $1,258 |
| 2017-06-30 | $1,212 |
| 2016-12-31 | $1,185 |
| 2015-12-31 | $1,138 |
| 2015-06-30 | $1,159 |
| 2014-12-31 | $1,166 |
| 2014-09-30 | $1,173 |
| 2014-06-30 | $1,207 |
| 2014-03-31 | $1,138 |
| 2013-12-31 | $1,113 |
| 2013-09-30 | $1,058 |
| 2013-06-30 | $1,046 |
| 2013-03-31 | $1,030 |
| 2012-12-31 | $1,065 |
| 2012-09-30 | $953 |
| 2012-06-30 | $1,001 |
| 2012-03-31 | $1,051 |
| 2011-12-31 | $1,037 |
| 2011-09-30 | $1,024 |
| 2011-06-30 | $1,050 |
| 2011-03-31 | $1,017 |
| 2010-12-31 | $1,024 |
| 2010-09-30 | $907 |
| 2010-06-30 | $884 |
| 2010-03-31 | $907 |
| 2009-12-31 | $946 |
| 2009-09-30 | $939 |
| 2009-06-30 | $964 |
| 2009-03-31 | $920 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $13.038B | $5.810B |
| Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.025B | 27.90 |
| Boston Scientific (BSX) | United States | $151.510B | 37.93 |
| Stryker (SYK) | United States | $148.668B | 31.08 |
| EssilorLuxottica (ESLOY) | France | $135.285B | 0.00 |
| Medtronic (MDT) | Ireland | $113.608B | 16.10 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.270B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.147B | 25.77 |
| ResMed (RMD) | United States | $37.623B | 28.26 |
| GE HealthCare Technologies (GEHC) | United States | $34.433B | 16.35 |
| Agilent Technologies (A) | United States | $34.375B | 22.41 |
| Terumo (TRUMY) | Japan | $24.785B | 32.19 |
| Koninklijke Philips (PHG) | Netherlands | $23.187B | 16.27 |
| Insulet (PODD) | United States | $20.867B | 81.91 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.493B | 11.88 |
| Baxter (BAX) | United States | $15.734B | 11.75 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.823B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.702B | 14.38 |
| Prestige Consumer Healthcare (PBH) | United States | $3.885B | 17.35 |
| Perrigo (PRGO) | Ireland | $3.731B | 9.46 |
| Haemonetics (HAE) | United States | $3.650B | 16.62 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.415B | 28.38 |
| ICU Medical (ICUI) | United States | $3.262B | 24.05 |
| QuidelOrtho (QDEL) | United States | $2.084B | 14.34 |
| LeMaitre Vascular (LMAT) | United States | $1.896B | 42.38 |
| AtriCure (ATRC) | United States | $1.566B | 0.00 |
| Acuren (TIC) | United States | $1.379B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.286B | 13.06 |
| Phibro Animal Health (PAHC) | United States | $1.221B | 15.61 |
| Green Thumb Industries (GTBIF) | United States | $1.211B | 27.24 |
| Neogen (NEOG) | United States | $1.137B | 14.56 |
| BioLife Solutions (BLFS) | United States | $1.071B | 0.00 |
| InMode (INMD) | Israel | $0.971B | 9.78 |
| Kestra Medical Technologies (KMTS) | United States | $0.810B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.703B | 0.00 |
| Owens & Minor (OMI) | United States | $0.695B | 5.76 |
| Curaleaf Holdings (CURLF) | Canada | $0.643B | 0.00 |
| CeriBell (CBLL) | United States | $0.619B | 0.00 |
| Evolus (EOLS) | United States | $0.597B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.594B | 0.00 |
| Valneva SE (VALN) | France | $0.497B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.465B | 0.00 |
| Surmodics (SRDX) | United States | $0.429B | 0.00 |
| SNDL (SNDL) | Canada | $0.363B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.347B | 12.77 |
| Quanterix (QTRX) | United States | $0.327B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.322B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.299B | 0.00 |
| Cerus (CERS) | United States | $0.279B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.277B | 23.40 |
| Sanara MedTech (SMTI) | United States | $0.269B | 0.00 |
| ZimVie (ZIMV) | United States | $0.268B | 12.19 |
| Cresco Labs (CRLBF) | United States | $0.265B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 76.00 |
| Brainsway (BWAY) | Israel | $0.243B | 64.35 |
| OraSure Technologies (OSUR) | United States | $0.227B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.226B | 0.00 |
| Biote (BTMD) | United States | $0.222B | 6.25 |
| TriSalus Life Sciences (TLSI) | United States | $0.196B | 0.00 |
| Organigram Global (OGI) | Canada | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.23 |
| Omeros (OMER) | United States | $0.183B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.127B | 15.61 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Fonar (FONR) | United States | $0.097B | 12.47 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Jin Medical (ZJYL) | China | $0.091B | 0.00 |
| Apyx Medical (APYX) | United States | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.073B | 0.00 |
| InterCure (INCR) | Israel | $0.072B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.066B | 0.00 |
| ImmuCell (ICCC) | United States | $0.060B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.57 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.84 |
| Safety Shot (SHOT) | United States | $0.032B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.032B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |